
Shobha Kantamneni
Examiner (ID: 1732, Phone: (571)272-2930 , Office: P/1627 )
| Most Active Art Unit | 1627 |
| Art Unit(s) | 1627, 1617, 1623 |
| Total Applications | 1212 |
| Issued Applications | 306 |
| Pending Applications | 120 |
| Abandoned Applications | 793 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 6825009
[patent_doc_number] => 20030235631
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-12-25
[patent_title] => 'Combination treatment for depression and anxiety'
[patent_app_type] => new
[patent_app_number] => 10/387060
[patent_app_country] => US
[patent_app_date] => 2003-03-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8383
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 75
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0235/20030235631.pdf
[firstpage_image] =>[orig_patent_app_number] => 10387060
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/387060 | Combination treatment for depression and anxiety | Mar 11, 2003 | Abandoned |
Array
(
[id] => 6797605
[patent_doc_number] => 20030176479
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-09-18
[patent_title] => 'Use of selective EP4 receptor agonists for the treatment of liver failure, loss of patency of the ductus arteriosus, glaucoma or ocular hypertension'
[patent_app_type] => new
[patent_app_number] => 10/386324
[patent_app_country] => US
[patent_app_date] => 2003-03-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8678
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0176/20030176479.pdf
[firstpage_image] =>[orig_patent_app_number] => 10386324
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/386324 | Use of selective EP4 receptor agonists for the treatment of liver failure, loss of patency of the ductus arteriosus, glaucoma or ocular hypertension | Mar 10, 2003 | Abandoned |
Array
(
[id] => 6830442
[patent_doc_number] => 20030181500
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-09-25
[patent_title] => 'Medicinal compositions for the prevention or treatment of cardiac failure'
[patent_app_type] => new
[patent_app_number] => 10/374171
[patent_app_country] => US
[patent_app_date] => 2003-02-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6444
[patent_no_of_claims] => 66
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0181/20030181500.pdf
[firstpage_image] =>[orig_patent_app_number] => 10374171
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/374171 | Medicinal compositions for the prevention or treatment of cardiac failure | Feb 25, 2003 | Abandoned |
Array
(
[id] => 6830449
[patent_doc_number] => 20030181507
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-09-25
[patent_title] => 'Use of 3-substituted oxindole derivatives as kcnq potassium channel modulators'
[patent_app_type] => new
[patent_app_number] => 10/312123
[patent_app_country] => US
[patent_app_date] => 2003-02-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 5550
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0181/20030181507.pdf
[firstpage_image] =>[orig_patent_app_number] => 10312123
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/312123 | Use of 3-substituted oxindole derivatives as kcnq potassium channel modulators | Feb 23, 2003 | Abandoned |
Array
(
[id] => 6847564
[patent_doc_number] => 20030166731
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-09-04
[patent_title] => 'Method of treating hair loss using diphenylether derivatives'
[patent_app_type] => new
[patent_app_number] => 10/373471
[patent_app_country] => US
[patent_app_date] => 2003-02-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9607
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0166/20030166731.pdf
[firstpage_image] =>[orig_patent_app_number] => 10373471
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/373471 | Method of treating hair loss using diphenylether derivatives | Feb 23, 2003 | Abandoned |
Array
(
[id] => 7432671
[patent_doc_number] => 20040162284
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-08-19
[patent_title] => 'Method of lowering body temperature with (S) tofisopam'
[patent_app_type] => new
[patent_app_number] => 10/369823
[patent_app_country] => US
[patent_app_date] => 2003-02-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 7795
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0162/20040162284.pdf
[firstpage_image] =>[orig_patent_app_number] => 10369823
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/369823 | Method of lowering body temperature with (S) tofisopam | Feb 18, 2003 | Abandoned |
Array
(
[id] => 6809628
[patent_doc_number] => 20030199567
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-10-23
[patent_title] => 'Combinations of an alpha-2-delta ligand with a selective inhibitor of cyclooxygenase-2'
[patent_app_type] => new
[patent_app_number] => 10/366798
[patent_app_country] => US
[patent_app_date] => 2003-02-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 32177
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0199/20030199567.pdf
[firstpage_image] =>[orig_patent_app_number] => 10366798
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/366798 | Combinations of an alpha-2-delta ligand with a selective inhibitor of cyclooxygenase-2 | Feb 13, 2003 | Abandoned |
Array
(
[id] => 6797638
[patent_doc_number] => 20030176512
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-09-18
[patent_title] => 'Asymmetric disulfides and methods of using same'
[patent_app_type] => new
[patent_app_number] => 10/366751
[patent_app_country] => US
[patent_app_date] => 2003-02-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 13218
[patent_no_of_claims] => 43
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0176/20030176512.pdf
[firstpage_image] =>[orig_patent_app_number] => 10366751
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/366751 | Asymmetric disulfides and methods of using same | Feb 13, 2003 | Abandoned |
Array
(
[id] => 6678159
[patent_doc_number] => 20030228299
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-12-11
[patent_title] => 'Use of antioxidant for treating and/or preventing surface ocular disorders'
[patent_app_type] => new
[patent_app_number] => 10/343840
[patent_app_country] => US
[patent_app_date] => 2003-02-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 7480
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 14
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0228/20030228299.pdf
[firstpage_image] =>[orig_patent_app_number] => 10343840
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/343840 | Use of antioxidant for treating and/or preventing surface ocular disorders | Feb 12, 2003 | Abandoned |
Array
(
[id] => 6797570
[patent_doc_number] => 20030176444
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-09-18
[patent_title] => 'Cytokine production inhibitors'
[patent_app_type] => new
[patent_app_number] => 10/344521
[patent_app_country] => US
[patent_app_date] => 2003-02-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 4296
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0176/20030176444.pdf
[firstpage_image] =>[orig_patent_app_number] => 10344521
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/344521 | Cytokine production inhibitors | Feb 11, 2003 | Abandoned |
Array
(
[id] => 7314545
[patent_doc_number] => 20040034037
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-02-19
[patent_title] => 'Heteroaryl compounds useful as inhibitors of GSK-3'
[patent_app_type] => new
[patent_app_number] => 10/360535
[patent_app_country] => US
[patent_app_date] => 2003-02-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20003
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 8
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0034/20040034037.pdf
[firstpage_image] =>[orig_patent_app_number] => 10360535
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/360535 | Heteroaryl compounds useful as inhibitors of GSK-3 | Feb 5, 2003 | Abandoned |
Array
(
[id] => 6711644
[patent_doc_number] => 20030171393
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-09-11
[patent_title] => 'Drugs for sex dysfunctions'
[patent_app_type] => new
[patent_app_number] => 10/333927
[patent_app_country] => US
[patent_app_date] => 2003-02-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6293
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0171/20030171393.pdf
[firstpage_image] =>[orig_patent_app_number] => 10333927
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/333927 | Drugs for sex dysfunctions | Feb 3, 2003 | Abandoned |
Array
(
[id] => 6787255
[patent_doc_number] => 20030138494
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-07-24
[patent_title] => 'Drug preparations for treating sexual dysfunction'
[patent_app_type] => new
[patent_app_number] => 10/357438
[patent_app_country] => US
[patent_app_date] => 2003-02-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9101
[patent_no_of_claims] => 102
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 73
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0138/20030138494.pdf
[firstpage_image] =>[orig_patent_app_number] => 10357438
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/357438 | Drug preparations for treating sexual dysfunction | Feb 3, 2003 | Abandoned |
Array
(
[id] => 6701144
[patent_doc_number] => 20030224024
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-12-04
[patent_title] => 'Compositions comprising cyclopentane derivatives and their use'
[patent_app_type] => new
[patent_app_number] => 10/356628
[patent_app_country] => US
[patent_app_date] => 2003-02-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4296
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0224/20030224024.pdf
[firstpage_image] =>[orig_patent_app_number] => 10356628
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/356628 | Compositions comprising cyclopentane derivatives and their use | Feb 2, 2003 | Abandoned |
Array
(
[id] => 6706804
[patent_doc_number] => 20030153538
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-08-14
[patent_title] => 'Antitumor agent'
[patent_app_type] => new
[patent_app_number] => 10/355201
[patent_app_country] => US
[patent_app_date] => 2003-01-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20620
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 25
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0153/20030153538.pdf
[firstpage_image] =>[orig_patent_app_number] => 10355201
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/355201 | Antitumor agent | Jan 30, 2003 | Abandoned |
Array
(
[id] => 6822149
[patent_doc_number] => 20030220310
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-11-27
[patent_title] => 'Epoxy-steroidal aldosterone antagonist and calcium channel blocker combination therapy for treatment of congestive heart failure'
[patent_app_type] => new
[patent_app_number] => 10/343165
[patent_app_country] => US
[patent_app_date] => 2003-01-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 38
[patent_figures_cnt] => 38
[patent_no_of_words] => 37247
[patent_no_of_claims] => 51
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 46
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0220/20030220310.pdf
[firstpage_image] =>[orig_patent_app_number] => 10343165
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/343165 | Epoxy-steroidal aldosterone antagonist and calcium channel blocker combination therapy for treatment of congestive heart failure | Jan 26, 2003 | Abandoned |
Array
(
[id] => 6668404
[patent_doc_number] => 20030113387
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-06-19
[patent_title] => 'Antipruritic composition and wound-healing-promoting composition'
[patent_app_type] => new
[patent_app_number] => 10/351335
[patent_app_country] => US
[patent_app_date] => 2003-01-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5717
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0113/20030113387.pdf
[firstpage_image] =>[orig_patent_app_number] => 10351335
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/351335 | Antipruritic composition and wound-healing-promoting composition | Jan 26, 2003 | Abandoned |
Array
(
[id] => 6835281
[patent_doc_number] => 20030162827
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-08-28
[patent_title] => 'HMG CoA reductase inhibiting composition, method of preparation thereof and method for competitively inhibiting HMG CoA reductase using such composition'
[patent_app_type] => new
[patent_app_number] => 10/349172
[patent_app_country] => US
[patent_app_date] => 2003-01-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5259
[patent_no_of_claims] => 61
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0162/20030162827.pdf
[firstpage_image] =>[orig_patent_app_number] => 10349172
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/349172 | HMG CoA reductase inhibiting composition, method of preparation thereof and method for competitively inhibiting HMG CoA reductase using such composition | Jan 22, 2003 | Abandoned |
Array
(
[id] => 7355810
[patent_doc_number] => 20040013643
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-01-22
[patent_title] => 'Methods for treatment of multiple sclerosis with statins'
[patent_app_type] => new
[patent_app_number] => 10/349549
[patent_app_country] => US
[patent_app_date] => 2003-01-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 22
[patent_no_of_words] => 19489
[patent_no_of_claims] => 49
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0013/20040013643.pdf
[firstpage_image] =>[orig_patent_app_number] => 10349549
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/349549 | Methods for treatment of multiple sclerosis with statins | Jan 21, 2003 | Abandoned |
Array
(
[id] => 6711642
[patent_doc_number] => 20030171391
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-09-11
[patent_title] => 'Ambroxol for the treatment of chronic pain'
[patent_app_type] => new
[patent_app_number] => 10/348283
[patent_app_country] => US
[patent_app_date] => 2003-01-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2378
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 44
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0171/20030171391.pdf
[firstpage_image] =>[orig_patent_app_number] => 10348283
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/348283 | Ambroxol for the treatment of chronic pain | Jan 20, 2003 | Abandoned |